Allogenetics

Hanover, Germany

Allogenetics provides aunique solution to the problem of organ rejection following transplantation.

$3.8M raised

Aug 2024

Seed

Top Investors

Carma FundNBank Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Allogenetics raised?

Allogenetics has raised $3.8M in total funding. The most recent round was Seed. The last funding was announced in August 2024.

Who are Allogenetics's investors?

Allogenetics's investors include Carma Fund, NBank Capital.

Where is Allogenetics headquartered?

Allogenetics is headquartered in Hanover, Germany.

What does Allogenetics do?

Allogenetics provides aunique solution to the problem of organ rejection following transplantation.

What stage is Allogenetics at?

Allogenetics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 29, 2024.

MLA

"Allogenetics — Funding & Investors." VCBacked, August 29, 2024, https://www.vcbacked.co/company/allogenetics. Accessed June 16, 2026.

APA

VCBacked. (2024). Allogenetics — Funding & Investors. Retrieved June 16, 2026, from https://www.vcbacked.co/company/allogenetics

Wikipedia (cite web)

{{cite web |title=Allogenetics — Funding & Investors |url=https://www.vcbacked.co/company/allogenetics |website=VCBacked |access-date=June 16, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 29, 2024.